Cryptic Aspergillus nidulans antimicrobials
- PMID: 21478304
- PMCID: PMC3127626
- DOI: 10.1128/AEM.02000-10
Cryptic Aspergillus nidulans antimicrobials
Abstract
Secondary metabolite (SM) production by fungi is hypothesized to provide some fitness attribute for the producing organisms. However, most SM clusters are "silent" when fungi are grown in traditional laboratory settings, and it is difficult to ascertain any function or activity of these SM cluster products. Recently, the creation of a chromatin remodeling mutant in Aspergillus nidulans induced activation of several cryptic SM gene clusters. Systematic testing of nine purified metabolites from this mutant identified an emodin derivate with efficacy against both human fungal pathogens (inhibiting both spore germination and hyphal growth) and several bacteria. The ability of catalase to diminish this antimicrobial activity implicates reactive oxygen species generation, specifically, the generation of hydrogen peroxide, as the mechanism of emodin hydroxyl activity.
Figures



References
-
- Aliaa R. E.-S. 2008. Control of root-rot diseases of Phaseolus vulgaris using gliotoxin. Malays J. 4:40–43
-
- Beattie K. D., et al. 2010. Antibacterial metabolites from Australian macrofungi from the genus Cortinarius. Phytochemistry 71:948–955 - PubMed
-
- Bentley S. D., et al. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417:141–147 - PubMed
-
- Bergmann S., et al. 2007. Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 3:213–217 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources